Structure-activity Studies of the Binding of the Flavonoid Scaffold to DNA
Background: Flavonoids have been shown to have a wide variety of biological activities and proven to be good scaffolds for the design of DNA-binding agents as anticancer therapeutics. Materials and Methods: In structure-activity relationship studies, flavonoid derivatives were designed and synthesis...
Gespeichert in:
Veröffentlicht in: | Anticancer research 2009-06, Vol.29 (6), p.2285-2293 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background: Flavonoids have been shown to have a wide variety of biological activities and proven to be good scaffolds for
the design of DNA-binding agents as anticancer therapeutics. Materials and Methods: In structure-activity relationship studies,
flavonoid derivatives were designed and synthesised through various organic synthesis protocols, resulting in novel or previously
described molecules. These were studied by UV-Vis absorbance and fluorescence spectroscopy as well as competition dialysis
for their binding to DNA isoforms. Their cytotoxic potential was assessed using MTS assays on MCF-7 breast cancer and CCRFCEM
leukaemia cell lines. Results and Conclusion: Introduction of moieties such as chloride, nitrogen, acetoxy and methoxy groups
did not help to improve binding affinity, but introduction of tertiary amines improved the binding 1,000-fold due to an improved
interaction of the compound with the nucleic acid; replacement of oxygen by sulphur increased the binding 7-fold, possibly
because sulphur being less electronegative than oxygen would allow the electrons of the molecule to interact more strongly
with the nucleic acid. Inhibition of growth by 50% (IG 50 ) values were moderate in breast and leukaemia cancer cell lines possibly due to the flavonoids interacting with other cellular
components besides the nucleic acids. |
---|---|
ISSN: | 0250-7005 1791-7530 |